Prevention of experimental autoimmune diabetes in mice by treatment with leflunomide.
Stosic-Grujicic
S
S
Institute for Biological Research, University of Belgrade, Yugoslavia.
Dimitrijevic
M
M
Bartlett
R R
RR
D000814:Aniline Compounds / Q000627:therapeutic use*; D000818:Animals; D003437:Crotonates; D003921:Diabetes Mellitus, Experimental / Q000473:pathology / Q000517:prevention & control*; D003922:Diabetes Mellitus, Type 1 / Q000517:prevention & control*; D005355:Fibrosis; D006885:Hydroxybutyrates / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007515:Islets of Langerhans / Q000187:drug effects / Q000473:pathology*; D007555:Isoxazoles / Q000627:therapeutic use*; D000077339:Leflunomide; D008297:Male; D051379:Mice; D008808:Mice, Inbred CBA; D009570:Nitriles; D014052:Toluidines
D000814:Aniline Compounds; D003437:Crotonates; D006885:Hydroxybutyrates; D007166:Immunosuppressive Agents; D007555:Isoxazoles; D009570:Nitriles; D014052:Toluidines; C527525:teriflunomide; D000077339:Leflunomide